CClinicalTrials.gg
RecruitingNCT07460258Updated Mar 10, 2026

A Study on the Effect of Medical Students' Literature Reading Patterns on Cognitive Load and Academic Writing Ability

An observational study in Accuracy in Understanding the Core Content of English Medical Literature, sponsored by Zhongnan Hospital. Recruiting at 3 sites in China. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Zhongnan Hospital · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 8 months later.
Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
160
Sex
All
01

Study summary

Compare the effects of three English medical literature reading modes (original text reading, bilingual comparison, full translation) on medical students' accuracy in literature comprehension, perceived cognitive load, mastery of professional terminology, and academic writing ability; assess whether reliance on artificial intelligence translation triggers a 'terminology shortage' phenomenon.

02

Conditions studied

  • Accuracy in Understanding the Core Content of English Medical Literature
03

In context

Lead sponsor

Zhongnan Hospital is the lead sponsor of 103 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Medical students who usually read English literature at school

Inclusion criteria

  • Students currently enrolled in our school's clinical medicine or related programs. Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Native English speakers or those with a background in translation. Previously, they have read the specific literature selected for this study.
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
160 participants (estimated)
Patient registry
No

Groups and cohorts

  • Original text reading
  • bilingual comparison
  • full text translation
06

What researchers measure

Primary outcomes

  1. Score for Objective Questions on Literature Comprehension

    Survey to evaluate literature comprehension under various reading modes

    Time frame: 1 week

07

Study locations

2 of 3 sites recruiting
  • Zhongnan Hospital of Wuhan University
    Wuhan, Hubei 430000, China
    Recruiting
  • Zhongnan Hospital of Wuhan University
    Wuhan, Hubei 430071, China
    Recruiting
  • Zhongnan Hospital
    Wuhan, Hubei, China
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07460258
Lead sponsor
Zhongnan Hospital
Responsible party
Sponsor
First posted
Mar 10, 2026
Start date
Jan 20, 2026
Primary completion
May 30, 2026 (estimated)
Completion
Jun 15, 2026 (estimated)
Last update
Mar 10, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion